ReviewInvestigative ophthalmology & visual science2026
Immunological Interplay at the Ocular Surface of Stevens-Johnson Syndrome, Ocular Cicatricial Pemphigoid, and Ocular Graft Versus Host Disease.
Review in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rare ocular surface inflammatory disorders (OSIDs), such as ocular cicatricial pemphigoid (OCP; 1.3-2/million), Stevens-Johnson Syndrome (SJS; 1-5/million), and ocular graft versus host disease (oGVHD; occurring in >50% of chronic GVHD cases) share overlapping clinical phenotypes. Their defining features include conjunctival cicatrization and chronic inflammation. An incomplete understanding of the underlying immunopathogenesis of these conditions has hindered the development of targeted therapies, leaving patients at risk of permanent vision loss and highlighting the need to define distinct ocular immune profiles. Existing literature indicates elevated levels of neutrophils and macrophages/monocytes, along with major increases in their related secretory factors, IL-8 (P < 0.05) and TNF-α (P < 0.05), at the ocular surface across all three groups. Whereas both B cells and cytotoxic T cells are elevated in oGVHD, OCP is characterized by elevated B cells and a concomitant reduction in cytotoxic T cells. Apart from neutrophils and macrophages/monocytes, the local immune landscape-especially in SJS-has been underexplored. At the molecular level, extensive studies of tears have reported elevated levels of IL-17, CXCR1 (P < 0.01), CTGF (P < 0.05) in OCP; IFN-α and IFN-γ (P < 0.05) in oGVHD; and MCP-1, MIP-1β (P < 0.05) in SJS. These studies also indicate that sampling methods and patients' medication status may influence immune profile outcomes. Comprehensive immunophenotyping studies, coupled with the establishment of pathological links to respective molecular profiles, could advance understanding of condition-specific disease biology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.